Leemans CR - Search Results

1

Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040).

Pai SI, Faivre S, Licitra L, Machiels JP, Vermorken JB, Bruzzi P, Gruenwald V, Giglio RE, Leemans CR, Seiwert TY, Soulieres D. Pai SI, et al. Among authors: leemans cr. J Immunother Cancer. 2019 Apr 3;7(1):96. doi: 10.1186/s40425-019-0578-0. J Immunother Cancer. 2019. PMID: 30944020 Free PMC article. Clinical Trial.

2

Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor.

Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB. Leemans CR, et al. Cancer. 1994 Jan 1;73(1):187-90. doi: 10.1002/1097-0142(19940101)73:1<187::aid-cncr2820730132>3.0.co;2-j. Cancer. 1994. PMID: 8275423

3

Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma.

Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB. Leemans CR, et al. Cancer. 1993 Jan 15;71(2):452-6. doi: 10.1002/1097-0142(19930115)71:2<452::aid-cncr2820710228>3.0.co;2-b. Cancer. 1993. PMID: 8422638

4

Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma.

Cloos J, Leemans CR, van der Sterre ML, Kuik DJ, Snow GB, Braakhuis BJ. Cloos J, et al. Among authors: leemans cr. Cancer Epidemiol Biomarkers Prev. 2000 Jul;9(7):713-7. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10919742

5

Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.

Tabor MP, Brakenhoff RH, van Houten VM, Kummer JA, Snel MH, Snijders PJ, Snow GB, Leemans CR, Braakhuis BJ. Tabor MP, et al. Among authors: leemans cr. Clin Cancer Res. 2001 Jun;7(6):1523-32. Clin Cancer Res. 2001. PMID: 11410486

6

Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study.

Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, Kummer JA, Leemans CR, Braakhuis BJ. Tabor MP, et al. Among authors: leemans cr. Clin Cancer Res. 2004 Jun 1;10(11):3607-13. doi: 10.1158/1078-0432.CCR-03-0632. Clin Cancer Res. 2004. PMID: 15173066

7

Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.

van Houten VM, Leemans CR, Kummer JA, Dijkstra J, Kuik DJ, van den Brekel MW, Snow GB, Brakenhoff RH. van Houten VM, et al. Among authors: leemans cr. Clin Cancer Res. 2004 Jun 1;10(11):3614-20. doi: 10.1158/1078-0432.CCR-03-0631. Clin Cancer Res. 2004. PMID: 15173067

8

Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients.

van Zeeburg HJ, Snijders PJ, Pals G, Hermsen MA, Rooimans MA, Bagby G, Soulier J, Gluckman E, Wennerberg J, Leemans CR, Joenje H, Brakenhoff RH. van Zeeburg HJ, et al. Among authors: leemans cr. Cancer Res. 2005 Feb 15;65(4):1271-6. doi: 10.1158/0008-5472.CAN-04-3665. Cancer Res. 2005. PMID: 15735012

9

Head and neck cancer: molecular carcinogenesis.

Braakhuis BJ, Brakenhoff RH, Leemans CR. Braakhuis BJ, et al. Among authors: leemans cr. Ann Oncol. 2005;16 Suppl 2:ii249-50. doi: 10.1093/annonc/mdi713. Ann Oncol. 2005. PMID: 15958466 Free article. No abstract available.

10

Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.

Langendijk JA, Slotman BJ, van der Waal I, Doornaert P, Berkof J, Leemans CR. Langendijk JA, et al. Among authors: leemans cr. Cancer. 2005 Oct 1;104(7):1408-17. doi: 10.1002/cncr.21340. Cancer. 2005. PMID: 16130134 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

504 results

Search Page